Trial Profile
A Phase I Study of Isavuconazole (active agent of the prodrug isavuconazonium sulfate) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2018
Price :
$35
*
At a glance
- Drugs Isavuconazonium (Primary)
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Adverse reactions
- 28 Feb 2018 New trial record